Fidelity Investments’s TScan Therapeutics TCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.8K Sell
10,878
-11,000
-50% -$16K ﹤0.01% 4371
2025
Q1
$30.2K Buy
21,878
+20,428
+1,409% +$28.2K ﹤0.01% 4074
2024
Q4
$4.41K Buy
1,450
+1,025
+241% +$3.12K ﹤0.01% 4686
2024
Q3
$2.12K Buy
+425
New +$2.12K ﹤0.01% 4796